Showing results (61-70 of 182) with videos related to
Sort By:
Pageof 19
American Heart Journal|February 3, 2009
Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialHerbert D Aronow, Steven R Steinhubl, Danielle M Brennan, et al.Vascular Medicine (London, England)|July 10, 2007
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic diseaseSteven R Steinhubl, Juan J Badimon, Deepak L Bhatt, et al.Clinical Cardiology|June 7, 2013
Development of a multi-institutional cohort to facilitate cardiovascular disease biomarker validation using existing biorepository samples linked to electronic health recordsDeanna S Cross, Catherine A McCarty, Steven R Steinhubl, et al.Journal of Clinical and Translational Science|November 27, 2020
Pregnancy health in POWERMOM participants living in rural versus urban zip codesJennifer M Radin, Shaquille Peters, Lauren Ariniello, et al.International Journal of Cardiology|March 20, 2010
Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary interventionGilles Montalescot, Genevieve Salette, Gabriel Steg, et al.The American Journal of Cardiology|September 3, 2004
Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat interventionJacqueline Saw, Eric J Topol, Steven R Steinhubl, et al.IEEE Journal of Biomedical and Health Informatics|July 11, 2018
Home Monitoring of Blood Pressure: Short-Term Changes During Serial Measurements for 56398 SubjectsGiorgio Quer, Nima Nikzad, Angela Chieh, et al.Thrombosis Research|July 17, 2007
Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effectSteven R Steinhubl, Jennifer J Oh, Julie H Oestreich, et al.Circulation. Cardiovascular Quality and Outcomes|October 31, 2023
Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS StudyMatthew R Reynolds, Amy B Stein, Xiaowu Sun, et al.Journal of Clinical Pharmacology|September 26, 2009
Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonistWendell S Akers, Jennifer J Oh, Julie H Oestreich, et al.Pageof 19